Oxi Pharma

Veterinary Medicine Manufacturer and Exporter in India

Exploring the Growth of Veterinary Medicine Manufacturer and Exporter in India

India will be working to become a world-class producer and exporter of veterinary products. Hence, finding a reliable Veterinary medicine manufacturer and exporter in India requires a lot of research.  India holds over 30% of the world’s livestock, and over 537 million animals of various species are found in the country. Agriculture and dairy farming contribute a considerable part of the economy, and almost 18% of India’s Gross Domestic Product (GDP) comes from this. The demand for effective veterinary care solutions, therefore, has touched a new peak. Plus, the veterinary pharmaceutical industry in India stands at over ₹8,000 crore.

Moreover, it is expected to touch ₹12,000 crore by 2027, growing at a compound annual growth rate (CAGR) of 9.2%. This is high due to increasing trends in rearing livestock, pet adoption, increased awareness about animal health, and a notable surge in outbreaks of diseases. Oxi Pharma is a reliable Veterinary medicine exporter in India. They are experiencing the benefits of this rising demand to produce export-quality medicines for local as well as foreign markets.

Veterinary Medicine Manufacturer and Exporter in India: From Volume to Value

  1. Low-cost veterinary medicines manufacturing in India is a value-driven innovation in the veterinary sector. Hence, India has more than 450 veterinary pharma units with production facilities in Gujarat, Maharashtra, Andhra Pradesh, and Telangana states. The states now supply the global market with injectables, oral products, dewormers, feed additives, and vaccines.
  2. Local producers are investing in technologically capable plants and establishing WHO-GMP, ISO, and GLP-licensed manufacturing units to compete internationally. Over 65% of Indian veterinary drug manufacturers are export-orientated.
  3. The relative strength of India is its low-cost manufacturing platform. India can manufacture high-quality medicines at a cost that is 30-40% lower than in America or Europe.
  4. Research and Development (R&D) is currently witnessing a record growth rate. Indian firms are investing close to 8% of their total annual turnover in R&D programmes. They specifically aimed at developing future-generation medicines for different diseases and long-acting injectables.
  5. Therefore, India’s exports of veterinary products jumped by 14%. The demand is expected to stay high owing to the enforcement of strict food safety laws across the world and the adoption of animal welfare laws.

Innovations Shaping the Future of Veterinary Pharma in India

Rise of Smart Manufacturing and Automation
India’s production efficiency of veterinary medicines is being increased with automation. In the course of veterinary medicines manufacturing in India, companies are adopting AI-powered quality control systems and automated blister pack machines. Moreover, such technologies reduce the risk of human error and lead to greater accuracy, especially in manufacturing sterile injectables. Plants also implement cleanroom processes, batch coding automation, and robotics-based formulation systems. The shift is saving production costs by 15–20% and production speed and regulatory compliance.  Advanced analytics and predictive maintenance are further improving machinery uptime and quality control.

Focus on Advanced Drug Delivery Systems
The Indian pharma industry has now surpassed the boundaries of generic oral and parenteral medicines. With the increasing number of sustained-release products, transdermal patches, and chewable tablets in animals, the industry is enhancing the simplicity of usage and acceptance of therapy. All these routes decrease animal stress as well as enhance the bioavailability of medicines.

 Integration of Herbal and Alternative Medicines
Consider India’s great tradition in herbal science and Ayurveda. A major proportion of Veterinary medicine exporter in India are working on the preparation of herbo-mineral veterinary medicines. Due to the growing demand for organic and antibiotic-free meat. There is also growing pressure for herbal dewormers, immunity tonics, and digestion tonics. TOF also has a series of ongoing studies on herbal veterinary medicines, thus also driving industry development. The Indian veterinary herbal drug market share rose by 22% in 2023, a definite sign of the shift towards natural and preventive medicine.

Final Words

India’s veterinary pharma industry is transforming at a rapid rate with innovation, low-cost production, and global demand. With huge quantities of livestock and a growing pet care market. The country is investing massively in infrastructure and R&D. However, the industry is scaling new heights with policies and public-private initiatives. Oxi Pharma is one of the leading Veterinary medicine manufacturer and exporter in India, with its world-class infrastructure. Moreover, it is setting new benchmarks as an Indian exporter and manufacturer of veterinary medicines with quality, affordability, and innovation.

Contact Details:

Company Name: Oxi Pharma
Phone: +91-9548355063
Email: oxipharma9@gmail.com
Address: Khasra No.122/13 MIN., Mauja Central
Hope Town, Dehradun Uttrakhand, India – 248197